A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry

European Journal of Cancer Care

Volumn 20, Issue 4, 2011, Pages 493-502

  Steinmetz, T ^a   Totzke, U ^b   Schweigert, M ^c   Mittermuller J ^d   Nawka, S ^c   Tesch, H ^e   Groschek, M ^f   Soling U ^g   Hellebrand, E ^h   Tsamaloukas, A ⁱ  

^a Outpatient Clinic   (Germany)

^b Totzke Scientific ^*  (Switzerland)

^c Outpatient Clinic   (Germany)

^d Outpatient Clinic   (Germany)

^e Outpatient Clinic Im Pruefling   (Germany)

^f Outpatient Clinic   (Germany)

^g Oncological Outpatient Clinics   (Germany)

^h Amgen Research GmbH   (Germany)

ⁱ Outpatient Clinic   (Germany)

Author keywords

Anaemia; ESA; Observational study; Transfusion; Treatment practice

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PROSPECTIVE STUDY; REGISTER;

AGED; ANEMIA; BLOOD TRANSFUSION; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 79958273187     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2010.01230.x     Document Type: Article

References (33)

1. Aapro M., Ludwig H., Bokemeyer C., Macdonald K., Soubeyran P., Turner M., Albrecht T. & Abraham I. (2009) Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study. Annals of Oncology 20, 1714-1721.
2. Auerbach M., Ballard H., Trout J.R., Mcilwain M., Ackerman A., Bahrain H., Balan S., Barker L. & Rana J. (2004) Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. Journal of Clinical Oncology 22, 1301-1307.
3. Barrett-Lee P., Bokemeyer C., Gascon P., Nortier J.W., Schneider M., Schrijvers D. & Van Belle S. (2005) Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. The Oncologist 10, 743-757.
4. Birgegard G., Gascon P. & Ludwig H. (2006) Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. European Journal of Haematology 77, 378-386.
5. Bokemeyer C., Aapro M.S., Courdi A., Foubert J., Link H., Osterborg A., Repetto L. & Soubeyran P. (2004) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. European Journal of Cancer 40, 2201-2216.
6. Bokemeyer C., Aapro M.S., Courdi A., Foubert J., Link H., Osterborg A., Repetto L. & Soubeyran P. (2007) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. European Journal of Cancer 43, 258-270.
7. Bundesärztekammer (2002) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Deutsches Ärzteblatt 99, A3359-A3362.
8. Colon-Otero G., Menke D. & Hook C.C. (1992) A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. The Medical Clinics of North America 76, 581-597.
9. Dubray B., Mosseri V., Brunin F., Jaulerry C., Poncet P., Rodriguez J., Brugere J., Point D., Giraud P. & Cosset J.M. (1996) Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 201, 553-558.
10. Fein D.A., Lee W.R., Hanlon A.L., Ridge J.A., Langer C.J., Curran W.J., Jr & Coia L.R. (1995) Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. Journal of Clinical Oncology 13, 2077-2083.
11. Glaser C.M., Millesi W., Kornek G.V., Lang S., Schull B., Watzinger F., Selzer E. & Lavey R.S. (2001) Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. International Journal of Radiation Oncology, Biology, Physics 50, 705-715.
12. Glaspy J., Crawford J., Vansteenkiste J., Henry D., Rao S., Bowers P., Berlin J.A., Tomita D., Bridges K. & Ludwig H. (2010) Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. British Journal of Cancer 102, 301-315.
13. Henke M., Laszig R., Rube C., Schafer U., Haase K.D., Schilcher B., Mose S., Beer K.T., Burger U., Dougherty C. & Frommhold H. (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362, 1255-1260.
14. Johnson M.A. (1990) Iron: nutrition monitoring and nutrition status assessment. The Journal of Nutrition 120 (Suppl. 11), 1486-1491.
15. Leite C. & Hoogstraten B. (1977) Differential diagnosis of anemia and cancer. CA: A Cancer Journal for Clinicians 27, 88-99.
16. Leyland-Jones B., Semiglazov V., Pawlicki M., Pienkowski T., Tjulandin S., Manikhas G., Makhson A., Roth A., Dodwell D., Baselga J., Biakhov M., Valuckas K., Voznyi E., Liu X. & Vercammen E. (2005) Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. Journal of Clinical Oncology 23, 5960-5972.
17. Littlewood T.J., Bajetta E., Nortier J.W., Vercammen E. & Rapoport B. (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. Journal of Clinical Oncology 19, 2865-2874.
18. Ludwig H., Van Belle S., Barrett-Lee P., Birgegard G., Bokemeyer C., Gascon P., Kosmidis P., Krzakowski M., Nortier J., Olmi P., Schneider M. & Schrijvers D. (2004) The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. European Journal of Cancer 40, 2293-2306.
19. Ludwig H., Aapro M., Bokemeyer C., Macdonald K., Soubeyran P., Turner M., Albrecht T. & Abraham I. (2009) Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study. European Journal of Cancer 45, 1603-1615.
20. Massey A.C. (1992) Microcytic anemia. Differential diagnosis and management of iron deficiency anemia. The Medical Clinics of North America 76, 549-566.
21. Pfeffer M.A., Burdmann E.A., Chen C.Y., Cooper M.E., De Zeeuw D., Eckardt K.U., Feyzi J.M., Ivanovich P., Kewalramani R., Levey A.S., Lewis E.F., Mcgill J.B., Mcmurray J.J., Parfrey P., Parving H.H., Remuzzi G., Singh A.K., Solomon S.D. & Toto R. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. The New England Journal of Medicine 361, 2019-2032.
22. Rath T., Mactier R.A., Weinreich T. & Scherhag A.W. (2009) Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study. Current Medical Research and Opinion 25, 961-970.
23. Rizzo J.D., Lichtin A.E., Woolf S.H., Seidenfeld J., Bennett C.L., Cella D., Djulbegovic B., Goode M.J., Jakubowski A.A., Lee S.J., Miller C.B., Rarick M.U., Regan D.H., Browman G.P. & Gordon M.S. (2002) Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 100, 2303-2320.
24. Rizzo J.D., Somerfield M.R., Hagerty K.L., Seidenfeld J., Bohlius J., Bennett C.L., Cella D.F., Djulbegovic B., Goode M.J., Jakubowski A.A., Rarick M.U., Regan D.H. & Lichtin A.E. (2008a) Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. Journal of Clinical Oncology 26, 132-149.
25. Rizzo J.D., Somerfield M.R., Hagerty K.L., Seidenfeld J., Bohlius J., Bennett C.L., Cella D.F., Djulbegovic B., Goode M.J., Jakubowski A.A., Rarick M.U., Regan D.H. & Lichtin A.E. (2008b) Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood 111, 25-41.
26. Smith R.E., Jr, Aapro M.S., Ludwig H., Pinter T., Smakal M., Ciuleanu T.E., Chen L., Lillie T. & Glaspy J.A. (2008) Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Oncology 26, 1040-1050.
27. Steinmetz T., Hellmich M., Neise M., Aldaud A., Lerchenmuller C., Tsamaloukas A., Fandel F., Weiligmann C., Totzke U. & Schmitz S. (2007) Prediction of the responsiveness to treatment with erythropoiesis-stimulating factors: a prospective clinical study in patients with solid tumors. The Oncologist 12, 748-755.
28. Steinmetz T., Totzke U., Soling U., Groschek M., Mittermuller J., Schweigert M., Tesch H., Nawka S., Schmitz S. & Tsamaloukas A. (2008) Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia - examination of practice in Germany. Current Medical Research and Opinion 24, 2751-2756.
29. Steinmetz T., Tsamaloukas A., Schmitz S., Wiegand J., Rohrberg R., Eggert J., Breuer F., Tessen H.W., Eustermann H. & Thomas L. (2010) A new concept for the differential diagnosis and therapy of anaemia in cancer patients. Support Care Cancer doi: 10.1007/s00520-010-0812-2
30. Thomas C. & Thomas L. (2002) Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clinical Chemistry 48, 1066-1076.
31. Unger E.F., Thompson A.M., Blank M.J. & Temple R. (2010) Erythropoiesis-stimulating agents - time for a reevaluation. The New England Journal of Medicine 362, 189-192.
32. Waters J.S., O'brien M.E. & Ashley S. (2002) Management of anemia in patients receiving chemotherapy. Journal of Clinical Oncology 20, 601-603.
33. Wright J.R., Ung Y.C., Julian J.A., Pritchard K.I., Whelan T.J., Smith C., Szechtman B., Roa W., Mulroy L., Rudinskas L., Gagnon B., Okawara G.S. & Levine M.N. (2007) Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. Journal of Clinical Oncology 25, 1027-1032.